NCT05230719

Brief Summary

The site of arterial access for coronary angiography and intervention has been the focus of research for decades as it is the source of major complications. Transradial access (TRA) reduces complications among patients undergoing percutaneous coronary procedures but is reported with the complication of radial artery occlusion (RAO) that limits the radial artery for future needs. Distal radial access (dTRA) has recently gained global popularity as an alternative access route for vascular procedures. Among the benefits of dTRA are the low risk of entry site bleeding complications, the low rate of radial artery occlusion, and improved patient and operator comfort. This study aims to reveal the feasibility and safety of dTRA and routine TRA procedures in acute coronary syndrome patients. The primary endpoints are forearm radical occlusion rate and major adverse cardiovascular events (MACEs) in the two groups. Investigators conduct this retrospected analysis to demonstrate the difference of the two procedure of Cannulation.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
2,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2019

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2019

Completed
3.1 years until next milestone

First Submitted

Initial submission to the registry

January 19, 2022

Completed
21 days until next milestone

First Posted

Study publicly available on registry

February 9, 2022

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2024

Completed
Last Updated

March 2, 2022

Status Verified

January 1, 2022

Enrollment Period

5 years

First QC Date

January 19, 2022

Last Update Submit

February 11, 2022

Conditions

Keywords

Distal Radial AccessRadial Artery OcclusionMajor Adverse Cardiovascular Events

Outcome Measures

Primary Outcomes (2)

  • Forearm radical

    Doppler ultrasound to determine whether patients suffer forearm radial occlusion

    2 years

  • MACEs

    Major Adverse Cardiovascular Events, including cardiovascular death, myocardial infarction and heart failure.

    2 years

Study Arms (2)

dTRA group

Investigators perform percutaneous coronary intervention by dTRA for patients

Procedure: Radial Artery Approach

TRA group

Investigators perform percutaneous coronary intervention by conventional TRA for patients

Procedure: Radial Artery Approach

Interventions

dTRA or conventional TRA for radical artery approach

TRA groupdTRA group

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All the patients who received coronary angiography, based on arterial cannulation procedure, were divided into two groups, dTRA and conventional TRA. We conduct this study to illustrate the complication and MACEs of these two kinds of access.

You may qualify if:

  • presence of a pulse in the snuffbox

You may not qualify if:

  • Absence of pulse
  • Ultrasound indication of arterial occlusion or severe calcification
  • Severe forearm artery malformation
  • Patients with severe liver and renal failure, or abnormal coagulation function
  • Established cardiogenic shock
  • History of previous coronary artery bypass grafting and radial artery use.
  • Raynaud's disease in the medical history

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Shenzhen People's hospital

Shenzhen, Guangdong, 518000, China

RECRUITING

MeSH Terms

Conditions

Acute Coronary SyndromeArterial Occlusive Diseases

Condition Hierarchy (Ancestors)

Myocardial IschemiaHeart DiseasesCardiovascular DiseasesVascular Diseases

Central Study Contacts

Tangzhiming Li, PhD.

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 19, 2022

First Posted

February 9, 2022

Study Start

January 1, 2019

Primary Completion

January 1, 2024

Study Completion

January 1, 2024

Last Updated

March 2, 2022

Record last verified: 2022-01

Data Sharing

IPD Sharing
Will not share

Locations